These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9691456)

  • 1. Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67.
    Vaishnav VV; Bacon BE; O'Neill M; Cherniak R
    Carbohydr Res; 1998 Jan; 306(1-2):315-30. PubMed ID: 9691456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactoxylomannans of Cryptococcus neoformans.
    James PG; Cherniak R
    Infect Immun; 1992 Mar; 60(3):1084-8. PubMed ID: 1541523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extracellular galactoxylomannan of acapsular Cryptococcus laurentii mutant.
    Capek P; Dudíková J; Matulová M; Kolarova N
    Int J Biol Macromol; 2008 Nov; 43(4):394-6. PubMed ID: 18706925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
    Turner SH; Cherniak R
    Carbohydr Res; 1991 Apr; 211(1):103-16. PubMed ID: 1773425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
    De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A
    Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
    Cherniak R; Morris LC; Meyer SA
    Carbohydr Res; 1992 Mar; 225(2):331-7. PubMed ID: 1643653
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
    Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
    Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.
    De Jesus M; Chow SK; Cordero RJ; Frases S; Casadevall A
    Eukaryot Cell; 2010 Jul; 9(7):1018-28. PubMed ID: 20061411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography-mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy.
    Cherniak R; Morris LC; Turner SH
    Carbohydr Res; 1992 Jan; 223():263-9. PubMed ID: 1596924
    [No Abstract]   [Full Text] [Related]  

  • 10. The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid.
    Heiss C; Klutts JS; Wang Z; Doering TL; Azadi P
    Carbohydr Res; 2009 May; 344(7):915-20. PubMed ID: 19345342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the 6-O-acetylated lipoglucuronomannogalactan a novel Cryptococcus neoformans cell wall polysaccharide.
    Previato JO; Vinogradov E; Silva MAE; Oliveira PAV; Fonseca LM; Maes E; Mendonça-Previato L
    Carbohydr Res; 2019 Mar; 475():1-10. PubMed ID: 30742969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.
    Grijpstra J; Gerwig GJ; Wösten H; Kamerling JP; de Cock H
    Eukaryot Cell; 2009 Aug; 8(8):1165-73. PubMed ID: 19542308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans.
    Gutierrez AL; Farage L; Melo MN; Mohana-Borges RS; Guerardel Y; Coddeville B; Wieruszeski JM; Mendonça-Previato L; Previato JO
    Glycobiology; 2007 Jun; 17(6):1-11C. PubMed ID: 17369287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies of a cell wall polysaccharide of Trichosporon asahii containing antigen II.
    Ichikawa T; Nishikawa A; Ikeda R; Shinoda T
    Eur J Biochem; 2001 Oct; 268(19):5098-106. PubMed ID: 11589701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-wall glucans of Cryptococcus neoformans Cap 67.
    James PG; Cherniak R; Jones RG; Stortz CA; Reiss E
    Carbohydr Res; 1990 Apr; 198(1):23-38. PubMed ID: 2191777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy.
    Besra GS; Khoo KH; McNeil MR; Dell A; Morris HR; Brennan PJ
    Biochemistry; 1995 Apr; 34(13):4257-66. PubMed ID: 7703239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.
    Ikeda R; Matsuyama H; Nishikawa A; Shinoda T; Fukazawa Y
    Microbiol Immunol; 1991; 35(2):125-38. PubMed ID: 1886490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.
    Villena SN; Pinheiro RO; Pinheiro CS; Nunes MP; Takiya CM; DosReis GA; Previato JO; Mendonça-Previato L; Freire-de-Lima CG
    Cell Microbiol; 2008 Jun; 10(6):1274-85. PubMed ID: 18284419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes.
    Reiss E; Huppert M; Cherniak R
    Curr Top Med Mycol; 1985; 1():172-207. PubMed ID: 3916766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
    Ikeda R; Maeda T
    Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.